Stock Market Today With IBD
Stock Market Today With IBD

Nov 18, 2026 · 28 min

Nvidia rally fades as Target and cybersecurity stocks stand out

Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In Focus

The session shows how sector rotation and rate uncertainty can obscure strength in individual stocks even when major indexes weaken.

3 key takeaways
  1. 1The Nasdaq eked out a gain, but Nvidia failed to sustain its earnings-driven rally as the broader market remained fragile.
  2. 2Cybersecurity, Amazon and retail stocks showed relative strength while healthcare selling, oil prices and rate concerns pressured indexes.
  3. 3Target, Rhythm Pharmaceuticals and Affiliated Managers Group offered distinct technical and fundamental setups in a difficult market.

Don't miss

Target’s earnings-driven breakout from a cup-with-handle base is examined against the challenge of sustaining gains in a difficult market.

The brief

Alissa Coram and Ken Shreve review a mixed session: the Nasdaq eked out a gain while the Dow and S&P 500 fell, with retail strength emerging beneath the indexes.

Nvidia’s strong earnings, revenue growth and higher guidance failed to sustain an early rally, underscoring uncertainty around the company and broader technology weakness.

Cybersecurity stocks outperformed despite tech-sector pressure, while Amazon and retail also showed leadership as oil prices, Treasury yields and possible rate hikes shaped sentiment.

Target broke out from a cup-with-handle base after strong earnings and sales growth, but the hosts stress the challenge of holding a breakout in a weak market.

Rhythm Pharmaceuticals and Affiliated Managers Group offered contrasting setups: a biotech emerging from consolidation and an investment firm returning to a buy zone.

What was said on this episode

21 statements · 14 positive · 3 negative · 4 neutral

  1. Nvidia reported strong earnings.

    “it was a pretty good earnings report for Nvidia”

    Listen at 2:22

  2. Ken Shreveon SEC investigation into NvidiaNegative4:54

    The SEC launched an investigation into Nvidia.

    “The SEC investigation was launched yesterday.”

    Listen at 4:54

  3. Ken Shreveon Oil pricesNegative7:38

    Oil prices fell below $83 per barrel.

    “Oil, the price of oil is down below $83 a barrel.”

    Listen at 7:38

  4. Ken Shreveon Federal Reserve half-point rate hikeNegative9:56

    Fed funds futures imply a slim chance of a half-point hike.

    “the chances are still, if you look at the Fed funds futures, it's still pretty slim chance it's gonna be, they're gonna bring the bazooka out and hike by a half a point”

    Listen at 9:56

  5. Ken Shreveon Federal Reserve quarter-point rate hikeNeutral10:18

    Markets largely price in a quarter-point rate hike.

    “But a quarter point is pretty much baked in at this point.”

    Listen at 10:18

  6. Ken Shreveon Cybersecurity softwarePositive12:21

    Cybersecurity software remains an attractive technology area.

    “that's an area of tech that is still looking interesting”

    Listen at 12:21

  7. Ken Shreveon AnthropicNeutral13:39

    Amazon and Alphabet own approximately 30% of Anthropic.

    “I think they own about 30% of Anthropic.”

    Listen at 13:39

  8. Anthropic would likely begin trading one or more hours after the open.

    “likely not going to start trading for at least an hour or 2 after the open, probably longer”

    Listen at 15:27

  9. Traders should manage risk and wait for a pattern before entering IPOs.

    “traders should just be careful out there, manage risk, wait for some sort of pattern to develop before getting in”

    Listen at 15:58

  10. Ken Shreveon Anthropic IPOPositive17:14

    Demand for Anthropic’s IPO is strong.

    “I think clearly the demand is strong”

    Listen at 17:14

  11. Ken Shreveon Anthropic IPO pricingPositive17:24

    Anthropic’s IPO price will likely exceed $70–$78.

    “it's likely gonna go off well above that $70 to $78 range”

    Listen at 17:24

  12. Ken Shreveon Target quarterly resultsPositive19:15

    Target reported a very strong quarter.

    “the quarter was very, very strong”

    Listen at 19:15

  13. Ken Shreveon Target business turnaroundPositive20:39

    Target’s business turnaround currently appears successful.

    “the turnaround's looking pretty good”

    Listen at 20:39

  14. Rhythm Pharmaceuticals treats a rare genetic form of obesity.

    “they treat a very rare form, a genetic form of obesity”

    Listen at 22:01

  15. Rhythm Pharmaceuticals’ drug received approval for an additional indication.

    “The drug just got an additional indication approved”

    Listen at 22:35

  16. Rhythm Pharmaceuticals has strong revenue growth and fund sponsorship.

    “Good revenue growth, good fund sponsorship.”

    Listen at 24:16

  17. Rhythm Pharmaceuticals is an institutionally supported, high-quality biotech.

    “this one, $119 stock, so I would definitely call it an institutional exceptional quality biotech”

    Listen at 24:28

  18. Rhythm Pharmaceuticals is worth watching based on its technical setup.

    “good name to watch and like the technicals here quite a bit”

    Listen at 24:40

  19. Ken Shreveon Affiliated Managers GroupNeutral25:07

    Affiliated Managers Group buys stakes in small and medium-sized investment boutiques.

    “they go around and they buy stakes in a lot of small and medium-sized investment boutiques”

    Listen at 25:07

  20. Ken Shreveon Affiliated Managers GroupPositive26:01

    Affiliated Managers Group has moved back into a buy zone.

    “this is a stock that has just moved back into a a buy zone”

    Listen at 26:01

  21. Ken Shreveon Affiliated Managers GroupPositive27:07

    Affiliated Managers Group is back in a buy zone.

    “Affiliated Managers Group, AMG, back in a buy zone here”

    Listen at 27:07

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Weekly email

State of the Pod, every Monday

The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.

Listen to the full episode and explore every guest, topic, and moment on PodLume.